Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study

By J. Blom, J. Vanderschoot, M. Oostindiër, S. Osanto, F. V. D. Meer, F. Rosendaal. Journal of Thrombosis and Haemostasis, 2006

674 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients (2008, result): “2-fold increase in VTE compared with cancer patients not receiving chemotherapy.(22) However, to our knowledge, prior studies of hospitalized patients have not separately evaluated the risk in patients receiving chemotherapy.”
Epidemiology and risk factors for venous thrombosis. (2007, background): “Cancers of the ovary, pancreas, lung, stomach, and hematological malignancies had a high incidence of venous thromboembolism in the year before the cancer diagnosis, pointing out the possible role of occult cancer in causing thrombosis or a commonality of risk factors for both diseases (35).”
Epidemiology of cancer-associated venous thrombosis. (2013, background): “In the literature, high risks are additionally reported for lymphomas, myeloma, and kidney, stomach, and bone cancer.(11,14,18,21) Relatively low risks are generally seen in patients with breast or prostate cancer.”